Johansson M - Search Results

1

The tyrosine kinase inhibitor ZD6474 inhibits tumour growth in an intracerebral rat glioma model.

Sandström M, Johansson M, Andersson U, Bergh A, Bergenheim AT, Henriksson R. Sandström M, et al. Among authors: johansson m. Br J Cancer. 2004 Sep 13;91(6):1174-80. doi: 10.1038/sj.bjc.6602108. Br J Cancer. 2004. PMID: 15305185 Free PMC article.

2

Tumor blood flow and the cytotoxic effects of estramustine and its constituents in a rat glioma model.

Johansson M, Bergenheim AT, Henriksson R, Koskinen LO, Vallbo C, Widmark A. Johansson M, et al. Neurosurgery. 1997 Jul;41(1):237-43; discussion 243-4. doi: 10.1097/00006123-199707000-00038. Neurosurgery. 1997. PMID: 9218312

3

Decrement of blood flow precedes the involution of the ventral prostate in the rat after castration.

Lekås E, Johansson M, Widmark A, Bergh A, Damber JE. Lekås E, et al. Among authors: johansson m. Urol Res. 1997;25(5):309-14. doi: 10.1007/BF01294656. Urol Res. 1997. PMID: 9373910

4

VEGF and tPA co-expressed in malignant glioma.

Lindgren M, Johansson M, Sandström J, Jonsson Y, Bergenheim AT, Henriksson R. Lindgren M, et al. Among authors: johansson m. Acta Oncol. 1997;36(6):615-8. doi: 10.3109/02841869709001324. Acta Oncol. 1997. PMID: 9408152

5

Distribution of estramustine in the BT4C rat glioma model.

Johansson M, Bergenheim AT, D'Argy R, Edman K, Gunnarsson PO, Widmark A, Henriksson R. Johansson M, et al. Cancer Chemother Pharmacol. 1998;41(4):317-25. doi: 10.1007/s002800050745. Cancer Chemother Pharmacol. 1998. PMID: 9488601

6

Effects of radiotherapy and estramustine on the microvasculature in malignant glioma.

Johansson M, Bergenheim AT, Widmark A, Henriksson R. Johansson M, et al. Br J Cancer. 1999 Apr;80(1-2):142-8. doi: 10.1038/sj.bjc.6690333. Br J Cancer. 1999. PMID: 10389990 Free PMC article.

7

Expression of the proteolytic factors, tPA and uPA, PAI-1 and VEGF during malignant glioma progression.

Sandström M, Johansson M, Sandström J, Bergenheim AT, Henriksson R. Sandström M, et al. Among authors: johansson m. Int J Dev Neurosci. 1999 Aug-Oct;17(5-6):473-81. doi: 10.1016/s0736-5748(99)00050-7. Int J Dev Neurosci. 1999. PMID: 10571409

8

Correlation of vascular endothelial growth factor content with recurrences, survival, and first relapse site in primary node-positive breast carcinoma after adjuvant treatment.

Linderholm B, Grankvist K, Wilking N, Johansson M, Tavelin B, Henriksson R. Linderholm B, et al. Among authors: johansson m. J Clin Oncol. 2000 Apr;18(7):1423-31. doi: 10.1200/JCO.2000.18.7.1423. J Clin Oncol. 2000. PMID: 10735889

9

Interleukin-2 and histamine in combination inhibit tumour growth and angiogenesis in malignant glioma.

Johansson M, Henriksson R, Bergenheim AT, Koskinen LO. Johansson M, et al. Br J Cancer. 2000 Sep;83(6):826-32. doi: 10.1054/bjoc.2000.1354. Br J Cancer. 2000. PMID: 10952789 Free PMC article.

10

Spatial expression of VEGF-A in human glioma.

Johansson M, Brännström T, Bergenheim AT, Henriksson R. Johansson M, et al. J Neurooncol. 2002 Aug;59(1):1-6. doi: 10.1023/a:1016317407043. J Neurooncol. 2002. PMID: 12222833

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,515 results

Search Page